Nexavar (sorafenib) is a targeted cancer medication used to treat advanced liver cancer (hepatocellular carcinoma), advanced kidney cancer (renal cell carcinoma), and specific types of progressive, radioiodine-resistant thyroid cancer. As a multikinase inhibitor, it stops tumor growth and limits their blood supply.
